Evidence map›Paper›PMID 30254701›Full record

ArticleBeilstein journal of organic chemistry2018

A challenging redox neutral Cp*Co(III)-catalysed alkylation of acetanilides with 3-buten-2-one: synthesis and key insights into the mechanism through DFT calculations.

Andrew Kenny, Alba Pisarello, Arron Bird, Paula G Chirila, Alex Hamilton, Christopher J Whiteoak

Open access · diamondAbstract read
In one paragraph

Article in Beilstein journal of organic chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 9 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Andrew KennyDepartment of Biosciences and Chemistry, Sheffield Hallam University, Sheffield, S1 1WB, United Kingdom.
Alba PisarelloDepartment of Biosciences and Chemistry, Sheffield Hallam University, Sheffield, S1 1WB, United Kingdom.
Arron BirdDepartment of Biosciences and Chemistry, Sheffield Hallam University, Sheffield, S1 1WB, United Kingdom.
Paula G ChirilaDepartment of Biosciences and Chemistry, Sheffield Hallam University, Sheffield, S1 1WB, United Kingdom.
Alex HamiltonDepartment of Biosciences and Chemistry, Sheffield Hallam University, Sheffield, S1 1WB, United Kingdom.
Christopher J WhiteoakDepartment of Biosciences and Chemistry, Sheffield Hallam University, Sheffield, S1 1WB, United Kingdom.ORCID 0000-0003-1501-5582
Sheffield Hallam University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional, established palladium cross-coupling procedures are widely applied in complex molecule synthesis; however, there is a significant disadvantage in the requirement for pre-functionalised substrates (commonly halides/triflates). Direct C-H activation protocols provide the opportunity for a novel approach to synthesis, although this field is still in its relative infancy and often transferability between substrate classes remains unresolved and limitations not fully understood. This study focuses on the translation of an established Cp*Co(III)-catalysed alkylation of benzamides to related acetanilides using 3-buten-2-one as coupling partner. The developed procedure provides a wide substrate scope in terms of substituted acetanilides, although the optimised conditions were found to be more forcing than those for the corresponding benzamide substrates. Interestingly, density functional theory (DFT) studies reveal that the major impediment in the mechanism is not the C-H activation step, but instead and unexpectedly, effective competition with more stable compounds (resting states) not involved in the catalytic cycle.

Indexed as

acetanilidesalkylationC–H activationcobalt catalysisDFT studies

Identifiers

PMID30254701
PMCPMC6142744
OpenAlexW2889654031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.